Objectives : The purpose of this research was to determine the levels of platelet, leukocyte,
and endothelial activation and markers of cellular interactions in patients with venous …

Rationale: The causes and circumstances surrounding death are understudied in patients
with pulmonary arterial hypertension (PAH). Objectives: We sought to determine the specific …

Treatment strategies for complex patients with pulmonary embolism (PE) are often debated
given patient heterogeneity, multitude of available treatment modalities, and lack of …

Rationale: High-density lipoprotein cholesterol (HDL-C) promotes healthy vascular function,
and it is decreased in insulin resistance. Insulin resistance predisposes to pulmonary …

Background Thrombosis and pulmonary embolism appear to be major causes of mortality in
hospitalized coronavirus disease 2019 (COVID-19) patients. However, few studies have …

ISHLT members have recognized the importance of a consensus statement on the evaluation
and management of patients with chronic thromboembolic pulmonary hypertension. The …

Noninvasive biomarkers are needed to aid in making challenging clinical decisions in
pulmonary arterial hypertension (PAH). Several biomarkers have been described, but only the …

Background Little is known about the association between left ventricular (LV) diastolic
dysfunction and outcomes in patients with idiopathic or heritable pulmonary arterial hypertension …

Pulmonary arterial hypertension (PAH) remains a disease with limited therapeutic options
and dismal prognosis. Despite its etiologic heterogeneity, the underlying unifying …

Background We provide the first multicenter analysis of patients cared for by eight Pulmonary
Embolism Response Teams (PERTs) in the United States (US); describing the frequency of …